Titilope A. Ishola, Dai H. Chung

Research output: Contribution to journalReview articlepeer-review

55 Scopus citations


Neuroblastomas continue to remain a clinical challenge, despite advances in multimodal therapy. Currently, studies are aimed at novel targets for neuroblastoma directed toward poor prognostic indicators such as the MYCN oncogene and marked angiogenesis. There have also been recent discoveries in neuroblastoma pathogenesis involving epigenetic regulation and retinoic acid therapy. Understanding the intricate complexities of this tumor may lead to innovative agents for more effective combinational therapy.

Original languageEnglish (US)
Pages (from-to)149-156
Number of pages8
JournalSurgical Oncology
Issue number3
StatePublished - Nov 2007
Externally publishedYes


  • MYCN
  • Neuroblastoma
  • Tumor regression

ASJC Scopus subject areas

  • Surgery
  • Oncology


Dive into the research topics of 'Neuroblastoma'. Together they form a unique fingerprint.

Cite this